-
- A Earl-Slater.
- Department of Medicines Management, Keele University.
- Health Serv J. 1999 May 6; 109 (5653): 18-20.
AbstractThe government has proposed a statutory scheme to regulate prices and profits on the sale of drugs to the NHS. Drug companies which don't cooperate could be liable to heavy fines, but the government has failed to spell out the precise conditions under which such penalties would apply. Defining what comprises excessive prices or profits is likely to present a number of empirical problems. Experience overseas suggests that the scheme will fail to halt the inexorable rise in the NHS drugs bill.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.